diclofenac has been researched along with 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3h-1,2-dithiol-3-thione-5-yl)phenyl ester in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Del Soldato, P; Lee, LC; Li, L; Moore, PK; Rossoni, G; Sparatore, A | 1 |
| Bhatia, M; Li, L; Moore, PK; Sidhapuriwala, J; Sparatore, A | 1 |
| Berti, F; Del Soldato, P; Manfredi, B; Rossoni, G; Sparatore, A; Tazzari, V | 1 |
| Baskar, R; Del Soldato, P; Moore, PK; Sparatore, A | 1 |
| Bass, SE; Cheng, RY; Del Soldato, P; Macdonald, CJ; Moody, TW; Roberts, DD; Sienkiewicz, P; Sparatore, A; Wink, DA; Yeh, GC | 1 |
| Del Soldato, P; Frantzias, J; Idris, AI; Logan, JG; Mollat, P; Ralston, SH; Sparatore, A | 1 |
| Guo, C; Liu, Q; Shi, C; Sparatore, A; Wang, C; Zhang, A; Zhang, H; Zhang, Y | 1 |
7 other study(ies) available for diclofenac and 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3h-1,2-dithiol-3-thione-5-yl)phenyl ester
| Article | Year |
|---|---|
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative.
Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Diclofenac; Drug Evaluation, Preclinical; Gastrointestinal Tract; Lipopolysaccharides; Male; Models, Biological; Rats; Rats, Sprague-Dawley; Shock, Septic; Thiones | 2007 |
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hindlimb; Hydrogen Sulfide; Injections; Male; Neutrophils; Nitrates; Nitrites; Peroxidase; Rats; Rats, Wistar; Thiones | 2007 |
The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart.
Topics: Animals; Creatine Kinase; Diclofenac; Epoprostenol; Glutathione; Glyburide; Heart; Hydrogen Sulfide; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Sulfides; Thiones; Ventricular Function, Left | 2008 |
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Diclofenac; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; Fluorescent Dyes; Hydrogen Sulfide; In Vitro Techniques; Indoles; Mitotic Index; Myocytes, Smooth Muscle; Rats; Thiones | 2008 |
Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cytochrome P-450 CYP1A1; Diclofenac; Humans; Liver Neoplasms; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; RNA, Messenger; Sulindac; Thiones | 2009 |
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Diclofenac; Female; Humans; Hydrogen Sulfide; I-kappa B Kinase; Mice; NF-kappa B; Osteoclasts; Osteolysis; Sulfones; Thiones | 2012 |
S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodeling.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Diclofenac; Down-Regulation; Doxorubicin; Gap Junctions; Heart; Mice; Oxidative Stress; Thiones | 2011 |